Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8142 |
Intermediate Similarity |
NPD8053 |
Approved |
0.8142 |
Intermediate Similarity |
NPD8054 |
Approved |
0.8132 |
Intermediate Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.8071 |
Intermediate Similarity |
NPD7827 |
Phase 1 |
0.8011 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7944 |
Intermediate Similarity |
NPD27 |
Approved |
0.7944 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7943 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7943 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7941 |
Intermediate Similarity |
NPD2420 |
Approved |
0.7941 |
Intermediate Similarity |
NPD2421 |
Approved |
0.7933 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7892 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7892 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7889 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7889 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7882 |
Intermediate Similarity |
NPD2422 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD3845 |
Phase 1 |
0.7861 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7796 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7796 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7796 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7796 |
Intermediate Similarity |
NPD7311 |
Approved |
0.776 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.776 |
Intermediate Similarity |
NPD8252 |
Approved |
0.776 |
Intermediate Similarity |
NPD8251 |
Approved |
0.7754 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7732 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7717 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD4584 |
Approved |
0.7684 |
Intermediate Similarity |
NPD7298 |
Approved |
0.766 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD4581 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD6788 |
Approved |
0.7647 |
Intermediate Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.7642 |
Intermediate Similarity |
NPD6723 |
Discontinued |
0.7586 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7554 |
Intermediate Similarity |
NPD4481 |
Phase 3 |
0.7554 |
Intermediate Similarity |
NPD2898 |
Approved |
0.75 |
Intermediate Similarity |
NPD6031 |
Approved |
0.75 |
Intermediate Similarity |
NPD6030 |
Approved |
0.75 |
Intermediate Similarity |
NPD4727 |
Phase 1 |
0.7475 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7475 |
Intermediate Similarity |
NPD3452 |
Approved |
0.7475 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7475 |
Intermediate Similarity |
NPD3450 |
Approved |
0.7461 |
Intermediate Similarity |
NPD2488 |
Approved |
0.7461 |
Intermediate Similarity |
NPD2490 |
Approved |
0.7446 |
Intermediate Similarity |
NPD4010 |
Discontinued |
0.7427 |
Intermediate Similarity |
NPD1632 |
Clinical (unspecified phase) |
0.7418 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7414 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7363 |
Intermediate Similarity |
NPD4582 |
Approved |
0.7363 |
Intermediate Similarity |
NPD4583 |
Approved |
0.7354 |
Intermediate Similarity |
NPD8153 |
Approved |
0.7354 |
Intermediate Similarity |
NPD8152 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.735 |
Intermediate Similarity |
NPD5005 |
Approved |
0.735 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7348 |
Intermediate Similarity |
NPD4585 |
Approved |
0.7348 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD7201 |
Clinical (unspecified phase) |
0.7322 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7322 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7322 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7314 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7313 |
Intermediate Similarity |
NPD4002 |
Approved |
0.7313 |
Intermediate Similarity |
NPD4004 |
Approved |
0.7308 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7308 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7299 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7293 |
Intermediate Similarity |
NPD3384 |
Approved |
0.7293 |
Intermediate Similarity |
NPD3382 |
Approved |
0.7293 |
Intermediate Similarity |
NPD3383 |
Approved |
0.7278 |
Intermediate Similarity |
NPD554 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2974 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2975 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2973 |
Approved |
0.7263 |
Intermediate Similarity |
NPD6297 |
Approved |
0.7254 |
Intermediate Similarity |
NPD5087 |
Clinical (unspecified phase) |
0.7243 |
Intermediate Similarity |
NPD4666 |
Phase 3 |
0.724 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7236 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7207 |
Intermediate Similarity |
NPD5976 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD4040 |
Phase 1 |
0.7189 |
Intermediate Similarity |
NPD5709 |
Phase 3 |
0.7177 |
Intermediate Similarity |
NPD7047 |
Phase 3 |
0.7175 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7164 |
Intermediate Similarity |
NPD4580 |
Approved |
0.7158 |
Intermediate Similarity |
NPD42 |
Phase 2 |
0.7158 |
Intermediate Similarity |
NPD6042 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD3647 |
Clinical (unspecified phase) |
0.715 |
Intermediate Similarity |
NPD2971 |
Approved |
0.715 |
Intermediate Similarity |
NPD2968 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4772 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD4773 |
Phase 2 |
0.7136 |
Intermediate Similarity |
NPD6997 |
Phase 2 |
0.7127 |
Intermediate Similarity |
NPD4017 |
Approved |
0.7119 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD6853 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6851 |
Approved |
0.7112 |
Intermediate Similarity |
NPD6107 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7087 |
Intermediate Similarity |
NPD4859 |
Phase 1 |
0.7086 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7074 |
Intermediate Similarity |
NPD4166 |
Phase 2 |
0.7068 |
Intermediate Similarity |
NPD4873 |
Discontinued |
0.705 |
Intermediate Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.7043 |
Intermediate Similarity |
NPD5604 |
Discontinued |
0.7043 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD8095 |
Phase 1 |
0.7022 |
Intermediate Similarity |
NPD5160 |
Discontinued |
0.7017 |
Intermediate Similarity |
NPD3641 |
Approved |
0.7017 |
Intermediate Similarity |
NPD3640 |
Phase 3 |
0.7017 |
Intermediate Similarity |
NPD3639 |
Approved |
0.7016 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7011 |
Intermediate Similarity |
NPD37 |
Approved |
0.7 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6983 |
Remote Similarity |
NPD7124 |
Phase 2 |
0.6944 |
Remote Similarity |
NPD7598 |
Phase 2 |
0.6943 |
Remote Similarity |
NPD7479 |
Phase 2 |
0.6936 |
Remote Similarity |
NPD3109 |
Approved |
0.6936 |
Remote Similarity |
NPD3110 |
Approved |
0.693 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD3055 |
Approved |
0.6923 |
Remote Similarity |
NPD3053 |
Approved |
0.6923 |
Remote Similarity |
NPD7549 |
Discontinued |
0.691 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.691 |
Remote Similarity |
NPD4162 |
Approved |
0.6907 |
Remote Similarity |
NPD6996 |
Clinical (unspecified phase) |
0.6906 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6898 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6898 |
Remote Similarity |
NPD4965 |
Approved |
0.6898 |
Remote Similarity |
NPD4966 |
Approved |
0.6888 |
Remote Similarity |
NPD7281 |
Phase 3 |
0.6888 |
Remote Similarity |
NPD7280 |
Phase 3 |
0.6878 |
Remote Similarity |
NPD5677 |
Discontinued |
0.6875 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6868 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6866 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6865 |
Remote Similarity |
NPD6072 |
Discontinued |
0.6865 |
Remote Similarity |
NPD5089 |
Approved |
0.6865 |
Remote Similarity |
NPD5090 |
Approved |
0.686 |
Remote Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.6857 |
Remote Similarity |
NPD817 |
Approved |
0.6857 |
Remote Similarity |
NPD2568 |
Approved |
0.6857 |
Remote Similarity |
NPD823 |
Approved |
0.6854 |
Remote Similarity |
NPD4257 |
Approved |
0.6854 |
Remote Similarity |
NPD4256 |
Phase 2 |
0.6852 |
Remote Similarity |
NPD7907 |
Approved |
0.6851 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6851 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6848 |
Remote Similarity |
NPD6523 |
Clinical (unspecified phase) |
0.6847 |
Remote Similarity |
NPD7922 |
Phase 1 |
0.6845 |
Remote Similarity |
NPD2491 |
Approved |
0.6845 |
Remote Similarity |
NPD3448 |
Approved |
0.6845 |
Remote Similarity |
NPD3057 |
Approved |
0.6837 |
Remote Similarity |
NPD8318 |
Clinical (unspecified phase) |
0.6834 |
Remote Similarity |
NPD6841 |
Approved |
0.6834 |
Remote Similarity |
NPD6842 |
Approved |
0.6834 |
Remote Similarity |
NPD7243 |
Clinical (unspecified phase) |
0.6834 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6833 |
Remote Similarity |
NPD2677 |
Approved |
0.6829 |
Remote Similarity |
NPD6612 |
Phase 2 |
0.6821 |
Remote Similarity |
NPD2028 |
Clinical (unspecified phase) |
0.6816 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6813 |
Remote Similarity |
NPD3645 |
Discontinued |
0.6811 |
Remote Similarity |
NPD4675 |
Approved |
0.6811 |
Remote Similarity |
NPD4678 |
Approved |
0.68 |
Remote Similarity |
NPD3408 |
Clinical (unspecified phase) |
0.6798 |
Remote Similarity |
NPD5582 |
Discontinued |
0.6794 |
Remote Similarity |
NPD7584 |
Approved |
0.6788 |
Remote Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.6784 |
Remote Similarity |
NPD3857 |
Clinical (unspecified phase) |
0.6782 |
Remote Similarity |
NPD2674 |
Phase 3 |
0.678 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6778 |
Remote Similarity |
NPD5754 |
Discontinued |
0.6778 |
Remote Similarity |
NPD3977 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD6090 |
Discontinued |
0.6771 |
Remote Similarity |
NPD6625 |
Approved |
0.6771 |
Remote Similarity |
NPD4083 |
Discontinued |
0.6763 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6763 |
Remote Similarity |
NPD3516 |
Approved |
0.6763 |
Remote Similarity |
NPD2972 |
Approved |
0.6763 |
Remote Similarity |
NPD3515 |
Approved |
0.6763 |
Remote Similarity |
NPD5156 |
Approved |
0.6763 |
Remote Similarity |
NPD3533 |
Approved |
0.6763 |
Remote Similarity |
NPD5155 |
Approved |
0.6759 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6759 |
Remote Similarity |
NPD4665 |
Approved |
0.6754 |
Remote Similarity |
NPD7802 |
Discontinued |
0.675 |
Remote Similarity |
NPD3349 |
Phase 2 |
0.6748 |
Remote Similarity |
NPD5457 |
Discontinued |
0.6744 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6743 |
Remote Similarity |
NPD3061 |
Approved |
0.6743
|
Remote Similarity |
NPD3059 |
Approved |